|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mercury (organo) alkyl compounds (as Hg) | CAS | ||
|
|
RTECS | ||
|
Synonyms & Trade Names Synonyms vary depending upon the specific (organo) alkyl mercury compound. |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: TWA 0.01 mg/m3 ST 0.03 mg/m3 [skin] | ||
| OSHA PEL�: TWA 0.01 mg/m3 C 0.04 mg/m3 | |||
| IDLH 2 mg/m3 (as Hg) | Conversion | ||
|
Physical Description Appearance and odor vary depending upon the specific (organo) alkyl mercury compound. |
|||
|
Properties vary depending upon the specific (organo) alkyl mercury compound. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incompatibilities & Reactivities Strong oxidizers such as chlorine |
|||
|
Measurement Methods None available |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Respirator Recommendations
NIOSH/OSHA Up to 0.1 mg/m3: (APF = 10) Any supplied-air respirator Up to 0.25 mg/m3: (APF = 25) Any supplied-air respirator operated in a continuous-flow mode Up to 0.5 mg/m3: (APF = 50) Any supplied-air respirator that has a tight-fitting facepiece and is operated in a continuous-flow mode/(APF = 50) Any self-contained breathing apparatus with a full facepiece/(APF = 50) Any supplied-air respirator with a full facepiece Up to 2 mg/m3: (APF = 1000) Any supplied-air respirator operated in a pressure-demand or other positive-pressure mode Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Paresthesia; ataxia, dysarthria; vision, hearing disturbance; spasticity, jerking limbs; dizziness; salivation; lacrimation (discharge of tears); nausea, vomiting, diarrhea, constipation; skin burns; emotional disturbance; kidney injury; possible teratogenic effects | |
|
Target Organs
Eyes, skin, central nervous system, peripheral nervous system, kidneys |
|
| See also: INTRODUCTION |